Apixaban (Eliquis) for Stroke Prevention in Atrial Fibrillation | AAFP
Direct Oral Anticoagulants are High-Risk Medications with Potentially Complex Dosing | PSNet
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach | PLOS ONE
ELIQUIS® (apixaban) dosing for DVT & PE patients | ELIQUIS UK
Eliquis (Apixaban Tablets): Uses, Dosage, Side Effects, Interactions, Warning
Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation - ScienceDirect
ELIQUIS Dosage & Rx Info | Uses, Side Effects
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study - Staerk - 2018 - Journal of Internal Medicine - Wiley Online Library
ELIQUIS® (apixaban) dosing for NVAF patients | ELIQUIS UK
Target-Specific Oral Anticoagulants
Xa Inhibitors - Apixaban and Rivaroxaban Oral Xa ... | GrepMed
ELIQUIS® (apixaban) dosing for DVT & PE patients | ELIQUIS UK